1-800-457-3801

SCBT Portrait Logo
Seach Input

HLA-DRα siRNA and shRNA Plasmids (h)

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human; for corresponding mouse product, see HLA-DRα siRNA and shRNA Plasmids (m)
  • CRISPR/Cas9 KO Plasmids consists of HLA-DRα-specific 20 nt guide RNA sequences derived from the GeCKO (v2) library
  • For CRISPR gene knockout, gRNA sequences direct the Cas9 protein to induce a site-specific double strand break (DSB) in the genomic DNA
  • Target-specific CRISPR Plasmids for both gene knockout and activation are available. Please refer to the detailed product information in the tabs below
  • Gene knockdown or activation can be assayed using HLA-DRα Antibody (G-7): sc-55593
  • All products are provided as transfection-ready, purified plasmid DNA, except the Lentiviral Activation Particles which have been prepackaged as Lentiviral Particles for use with hard-to-transfect cells

QUICK LINKS

SEE ALSO...

Description

  • 10 µM, 50-100 transfections
  • siRNA products generally consist of pools of three to five target-specific 19-25 nt siRNAs designed to knockdown gene expression
  • for independent verification of HLA-DRα gene silencing results, individual siRNA duplex components are also available upon request
  • suitable control antibody: HLA-DRα Antibody (G-7): sc-55593
  • sqRT-PCR Primer also available: HLA-DRα (h)-PR: sc-37113-PR, 20 µl
  • Get details about si/shRNA Gene Silencers

See Protocol Online.

DOWNLOADS

QUICK LINKS

Description

  • 20 µl of each primer set is provided at a concentration of 10 µM
  • HLA-DRα Primer (h) includes A set (forward & reverse) and B set (forward & reverse) primers
  • Primer sets are recommended for semi-quantitative nested reverse transcriptase PCR

See Protocol Online.

QUICK LINKS

Description

  • 20 µg, up to 20 transfections
  • shRNA Plasmids generally consist of a pool of three to five lentiviral vector plasmids each encoding target-specific 19-25 nt (plus hairpin) shRNAs designed to knockdown gene expression
  • shRNA sequences correspond to HLA-DRα siRNA Gene Silencer sequences
  • provided as transfection-ready purified plasmid DNA target-specific gene silencing
  • after transfection, cells stably expressing shRNAs can be isolated by puromycin selection
  • shRNA Plasmids are intended only for non-commercial use.
  • suitable control antibody: HLA-DRα Antibody (G-7): sc-55593
  • sqRT-PCR Primer also available: HLA-DRα (h)-PR: sc-37113-PR, 20 µl

See Protocol Online.

QUICK LINKS

Description

  • 200 µl viral stock containing 1x 106 infectious units of virus (IFU) , sufficient for 10-20 transductions
  • Lentiviral Particles are provided as transduction-ready viral particles for gene silencing
  • Lentiviral Particles generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression
  • shRNA sequences correspond to HLA-DRα siRNA Gene Silencer sequences
  • After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin
  • Biosafety - Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
  • Lentiviral Particles are intended for non-commercial use.

See Protocol Online.

QUICK LINKS

loader

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

HLA-DRα siRNA (h)

sc-37113
10 µM
$293.00

HLA-DRα (h)-PR

sc-37113-PR
10 µM, 20 µl
$33.00

HLA-DRα shRNA Plasmid (h)

sc-37113-SH
20 µg
$592.00

HLA-DRα shRNA (h) Lentiviral Particles

sc-37113-V
200 µl
$711.00